p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer
Abdul Yassin‐Kassab(University of Pittsburgh), Umamaheswar Duvvuri(City University of New York), Nathaniel Wang(University of Pittsburgh), Timothy F. Burns(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Suman Chatterjee(UPMC Hillman Cancer Center), Nayel Khan(University of Pittsburgh Medical Center), Eric H.‐B. Huang(University of Pittsburgh), Vlad C. Sandulache(Michael E. DeBakey VA Medical Center)
Cited by 4
Related Papers
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
|Immunity|2020|688
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
|Cancer Discovery|2013|590
Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach
|International Journal of Molecular Sciences|2017|505
Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer
|Clinical Cancer Research|2014|401